Skip to main content
. 2022 Apr 20;14(9):2061. doi: 10.3390/cancers14092061

Figure 1.

Figure 1

Enhanced detection of cfDNA for its use as a biomarker for the diagnosis and prognosis of HCC. (A) A schematic diagram illustrating the cfDNA detection and analysis methods using PDA-SiO2 beads. (B) The copy numbers of plasma cfAFP-DNA isolated from human plasma samples using either PDA-SiO2 beads (black) or QIAamp DNA mini-kit (gray).